(A) The expression of ITGB1, ITGB3, and ITGA5 in breast cancer subclasses and normal breast tissue using The Cancer Genome Atlas (TCGA) samples (n = 114 of normal samples, n = 556, 37, and 116 of luminal, human epidermal growth factor receptor 2 [HER2] positive and TNBC samples, respectively; p-value is the result of comparison with normal samples, respectively). Here, ERBB2 is linked to breast carcinoma.